Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation

NCT02067182 ·Status: COMPLETED ·Phase: PHASE4

Left Atrial Thrombus Reduction - Effect of Dabigatran Versus Phenprocoumon

NCT02591225 ·Status: UNKNOWN ·Phase: PHASE4

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

NCT03254134 ·Status: COMPLETED

Predictive Factors for Response to New Oral Anticoagulants in the Treatment of Non-valvular Atrial Fibrillation..

NCT04297150 ·Status: UNKNOWN

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

NCT00558259 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

NCT02043808 ·Status: COMPLETED

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

NCT00291330 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With and Without Renal Impairment

NCT02182024 ·Status: COMPLETED ·Phase: PHASE1

Monitor System for the Safety of Dabigatran Treatment

NCT02414035 ·Status: COMPLETED

Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary Intervention

NCT00818753 ·Status: COMPLETED ·Phase: PHASE2

Edoxaban and Frailty in Senior Individuals

NCT03524924 ·Status: COMPLETED

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

NCT02164864 ·Status: COMPLETED ·Phase: PHASE3

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation

NCT01606995 ·Status: COMPLETED

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

NCT02072434 ·Status: COMPLETED ·Phase: PHASE3

Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy Participants

NCT03742336 ·Status: COMPLETED ·Phase: PHASE1

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

NCT02864758 ·Status: COMPLETED

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

NCT02666157 ·Status: UNKNOWN ·Phase: PHASE4

The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis

NCT03026556 ·Status: COMPLETED

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

NCT02792335 ·Status: COMPLETED

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

NCT00781391 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age

NCT01773174 ·Status: WITHDRAWN ·Phase: PHASE2

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

NCT00680186 ·Status: COMPLETED ·Phase: PHASE3

Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)

NCT02240667 ·Status: COMPLETED

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

NCT00808067 ·Status: COMPLETED ·Phase: PHASE3

Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

NCT02171455 ·Status: COMPLETED ·Phase: PHASE1